{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:08:42Z","timestamp":1787731722336,"version":"build-2784847793"},"reference-count":115,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Oradea, Romania"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Aortic stenosis (AS) and atherosclerosis are progressive cardiovascular conditions that frequently coexist and share multiple clinical and molecular features. Medical therapies have shown effectiveness in preventing and treating atherosclerosis and its consequences. For AS, effective pharmacological therapies remain limited. Understanding the shared risk factors and mechanisms between the two conditions may provide opportunities for therapeutic repositioning in AS. We performed a narrative review focusing on studies published from 2005 to 2025. Inclusion criteria encompassed clinical trials, experimental models, and molecular studies addressing overlapping risk factors, pathological pathways, and treatment approaches for AS and atherosclerosis. AS and atherosclerosis share key risk factors, including age, hypertension, hyperlipidemia, and diabetes. Molecular mechanisms, such as chronic inflammation, endothelial dysfunction, oxidative stress, lipid accumulation, and calcific remodeling, are common to both. Pathways involving the renin-angiotensin system, Notch signaling, and osteogenic mediators contribute to disease progression. Several drug classes, notably proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitors, lipoprotein(a) (Lp(a)) lowering therapies, anti-inflammatory agents, and immunomodulators, show potential for repositioning in AS management. The substantial overlap in risk factors and molecular mechanisms between AS and atherosclerosis supports a rationale for therapeutic repositioning. Targeting shared pathways could lead to innovative strategies for slowing AS progression and improving patient outcomes.<\/jats:p>","DOI":"10.3390\/ijms26178163","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T13:47:49Z","timestamp":1755870469000},"page":"8163","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Shared Risk Factors and Molecular Mechanisms Between Aortic Stenosis and Atherosclerosis: A Rationale for Therapeutic Repositioning"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0855-938X","authenticated-orcid":false,"given":"Corina","family":"Cinezan","sequence":"first","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Clinical County Emergency Hospital Bihor, 410169 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4883-3856","authenticated-orcid":false,"given":"Dan Claudiu","family":"Magureanu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, 40337 Cluj-Napoca, Romania"},{"name":"Cardiology Department, Niculae Stancioiu Heart Institute, 400001 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza","family":"Hiceag","sequence":"additional","affiliation":[{"name":"Cardiology Department, Rehabilitation Hospital, 400347 Cluj-Napoca, Romania"},{"name":"Cardiology Department, Municipal Hospital Aiud, 515200 Aiud, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9229-2656","authenticated-orcid":false,"given":"Camelia Bianca","family":"Rus","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Clinical County Emergency Hospital Bihor, 410169 Oradea, Romania"},{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Tiberia","family":"Ilias","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Clinical County Emergency Hospital Bihor, 410169 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia Denisa","family":"Bogdan","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Clinical County Emergency Hospital Bihor, 410169 Oradea, Romania"},{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Manuela","family":"Buzle","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Clinical County Emergency Hospital Bihor, 410169 Oradea, Romania"},{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3989-2291","authenticated-orcid":false,"given":"Angela","family":"Cozma","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejvs.2005.04.030","article-title":"Aortic Calcification","volume":"30","author":"Jayalath","year":"2005","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2017.01.025","article-title":"Association Between Cardiovascular Risk Factors and Aortic Stenosis","volume":"69","author":"Yan","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MED.0000000000000471","article-title":"Risk Factors for Valvular Calcification","volume":"26","author":"Chen","year":"2019","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-7120-4-27","article-title":"Epidemiology and Cardiovascular Risk Factors of Aortic Stenosis","volume":"4","author":"Faggiano","year":"2006","journal-title":"Cardiovasc. Ultrasound"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.ATV.0000227513.13697.ac","article-title":"Pathogenesis of Calcific Aortic Valve Disease: A Disease Process Comes of Age (and a Good Deal More)","volume":"26","year":"2006","journal-title":"ATVB"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/eurheartj\/ehad142","article-title":"Dyslipidemia, Inflammation, Calcification, and Adiposity in Aortic Stenosis: A Genome-Wide Study","volume":"44","author":"Chen","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.2174\/0929867328666210222092628","article-title":"Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 Monoclonal Antibodies","volume":"28","author":"Ali","year":"2021","journal-title":"CMC"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/eurheartj\/eht034","article-title":"Aortic Stenosis, Atherosclerosis, and Skeletal Bone: Is There a Common Link with Calcification and Inflammation?","volume":"34","author":"Dweck","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cjco.2024.06.002","article-title":"Molecular Features of Calcific Aortic Stenosis in Female and Male Patients","volume":"6","author":"Guisle","year":"2024","journal-title":"CJC Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ehjci\/jew013","article-title":"Systolic Hypertension and Progression of Aortic Valve Calcification in Patients with Aortic Stenosis: Results from the PROGRESSA Study","volume":"18","author":"Tastet","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e047645","DOI":"10.1136\/bmjopen-2020-047645","article-title":"Modified Effect of Active or Passive Smoking on the Association between Age and Abdominal Aortic Calcification: A Nationally Representative Cross-Sectional Study","volume":"11","author":"Lv","year":"2021","journal-title":"BMJ Open"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s12012-021-09677-8","article-title":"Aortic Valve Calcification Score in Patients with Arterial Hypertension Environmentally Exposed to Tobacco Smoke","volume":"21","author":"Martuszewski","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1093\/ndt\/gft310","article-title":"Aortic Valve Calcification in Chronic Kidney Disease","volume":"28","author":"Rattazzi","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Oikawa, M., Owada, T., Yamauchi, H., Misaka, T., Machii, H., Yamaki, T., Sugimoto, K., Kunii, H., Nakazato, K., and Suzuki, H. (2016). Predominance of Abdominal Visceral Adipose Tissue Reflects the Presence of Aortic Valve Calcification. BioMed Res. Int., 2016.","DOI":"10.1155\/2016\/2174657"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yexmp.2008.11.001","article-title":"Atherosclerotic Inflammation Triggers Osteogenic Bone Transformation in Calcified and Stenotic Human Aortic Valves: Still a Matter of Debate","volume":"86","author":"Anger","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2459\/01.JCM.0000268128.74413.1b","article-title":"Carotid Intima\u2013Media Thickness, Carotid Distensibility and Mitral, Aortic Valve Calcification: A Useful Diagnostic Parameter of Systemic Atherosclerotic Disease","volume":"8","author":"Sgorbini","year":"2007","journal-title":"J. Cardiovasc. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2018.08.029","article-title":"Inflammatory and Metabolic Mechanisms Underlying the Calcific Aortic Valve Disease","volume":"277","author":"Cho","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1093\/eurheartj\/ehx653","article-title":"Calcific Aortic Valve Stenosis: Hard Disease in the Heart","volume":"39","author":"Peeters","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jacc.2021.09.1367","article-title":"Evaluating Medical Therapy for Calcific Aortic Stenosis","volume":"78","author":"Lindman","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature03940","article-title":"Mutations in NOTCH1 Cause Aortic Valve Disease","volume":"437","author":"Garg","year":"2005","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/CRD.0000000000000510","article-title":"Pathological Mechanism and Treatment of Calcified Aortic Stenosis","volume":"32","author":"Chen","year":"2024","journal-title":"Cardiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Choi, B., Kim, E.-Y., Kim, J.-E., Oh, S., Park, S.-O., Kim, S.-M., Choi, H., Song, J.-K., and Chang, E.-J. (2021). Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification. Cells, 10.","DOI":"10.3390\/cells10010057"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ihj.2015.07.033","article-title":"Calcific Aortic Valve Disease: Is It Another Face of Atherosclerosis?","volume":"67","author":"Sathyamurthy","year":"2015","journal-title":"Indian Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e002244","DOI":"10.1136\/openhrt-2022-002244","article-title":"Pathophysiology, Emerging Techniques for the Assessment and Novel Treatment of Aortic Stenosis","volume":"10","author":"Shah","year":"2023","journal-title":"Open Heart"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.numecd.2015.02.001","article-title":"The Lipid Theory in the Pathogenesis of Calcific Aortic Stenosis","volume":"25","author":"Parisi","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e016372","DOI":"10.1161\/CIRCIMAGING.123.016372","article-title":"Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol","volume":"17","author":"Marrero","year":"2024","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","article-title":"High-Density Lipoprotein Revisited: Biological Functions and Clinical Relevance","volume":"44","author":"Nordestgaard","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jacl.2025.03.001","article-title":"Association between Lipoprotein(a) and Long-Term Prognosis in Patients Receiving Transcatheter Aortic Valve Replacement","volume":"19","author":"Hu","year":"2025","journal-title":"J. Clin. Lipidol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","article-title":"Lipoprotein(a) and Its Significance in Cardiovascular Disease: A Review","volume":"7","author":"Lau","year":"2022","journal-title":"JAMA Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"101543","DOI":"10.1016\/j.ijcha.2024.101543","article-title":"Role of Lipoprotein (A) in Aortic Valve Stenosis: Novel Disease Mechanisms and Emerging Pharmacotherapeutic Approaches","volume":"55","author":"Khan","year":"2024","journal-title":"IJC Heart Vasc."},{"key":"ref_31","first-page":"E48","article-title":"Lipoprotein(a): A genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: A scientific statement from the American Heart Association","volume":"42","author":"Ginsberg","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in Atherosclerotic Cardiovascular Disease and Aortic Stenosis: A European Atherosclerosis Society Consensus Statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.7150\/thno.71813","article-title":"The Mechanistic Pathways of Oxidative Stress in Aortic Stenosis and Clinical Implications","volume":"12","author":"Phua","year":"2022","journal-title":"Theranostics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCULATIONAHA.123.066523","article-title":"Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment Strategy to Slow Progression of Calcific Aortic Valve Stenosis: Preclinical and Randomized Clinical Trials to Assess Safety and Efficacy","volume":"151","author":"Zhang","year":"2025","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Fan, L., Yao, D., Fan, Z., Zhang, T., Shen, Q., Tong, F., Qian, X., Xu, L., Jiang, C., and Dong, N. (2024). Beyond VICs: Shedding Light on the Overlooked VECs in Calcific Aortic Valve Disease. Biomed. Pharmacother., 178.","DOI":"10.1016\/j.biopha.2024.117143"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"eadg0478","DOI":"10.1126\/sciadv.adg0478","article-title":"Activation of Piezo1 Promotes Osteogenic Differentiation of Aortic Valve Interstitial Cell through YAP-Dependent Glutaminolysis","volume":"9","author":"Zhong","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/heartjnl-2020-317024","article-title":"Dipeptidyl Peptidase-4 Inhibition to Prevent Progression of Calcific Aortic Stenosis","volume":"106","author":"Lee","year":"2020","journal-title":"Heart"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.116.024270","article-title":"Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells","volume":"135","author":"Choi","year":"2017","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e015261","DOI":"10.1161\/JAHA.119.015261","article-title":"Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis","volume":"9","author":"Saku","year":"2020","journal-title":"JAHA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/1479164118820657","article-title":"Aortic Stenosis and Diabetes Mellitus: An Ominous Combination","volume":"16","author":"Banovic","year":"2019","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s43044-023-00345-6","article-title":"Aortic Stenosis: A Review on Acquired Pathogenesis and Ominous Combination with Diabetes Mellitus","volume":"75","author":"Wal","year":"2023","journal-title":"Egypt. Heart J."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Basile, C., Fucile, I., Lembo, M., Manzi, M.V., Ilardi, F., Franzone, A., and Mancusi, C. (2021). Arterial Hypertension in Aortic Valve Stenosis: A Critical Update. JCM, 10.","DOI":"10.3390\/jcm10235553"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/HJH.0000000000002426","article-title":"Hypertension in Aortic Stenosis: A Focused Review and Recommendations for Clinical Practice","volume":"38","author":"Saeed","year":"2020","journal-title":"J. Hypertens."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacbts.2023.12.002","article-title":"Anemia, Increased Shear Stress, and the Progression of Aortic Stenosis","volume":"9","author":"Neelamegham","year":"2024","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/eurheartj\/ehac037","article-title":"Endothelial Cell-Derived Tetrahydrobiopterin Prevents Aortic Valve Calcification","volume":"43","author":"Liu","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11657-023-01339-2","article-title":"Increasing Baseline Aortic Valve Peak Flow Velocity Is Associated with Progression of Aortic Valve Stenosis in Osteoporosis Patients\u2014A Possible Link to Low Vitamin D Status","volume":"18","author":"Tsuruda","year":"2023","journal-title":"Arch. Osteoporos."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.20452\/pamw.3335","article-title":"Aortic Stenosis: New Pathophysiological Mechanisms and Future Perspectives for Pharmacological Therapy","volume":"126","author":"Dimitrow","year":"2016","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2009.03.108","article-title":"Molecular and Cellular Mechanisms of Aortic Stenosis","volume":"135","author":"Yetkin","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12265-018-9804-2","article-title":"RANKL Expression Is Increased in Circulating Mononuclear Cells of Patients with Calcific Aortic Stenosis","volume":"11","author":"Rattazzi","year":"2018","journal-title":"J. Cardiovasc. Trans. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2324-8602.1000249","article-title":"Denosumab Could Be a Potential Inhibitor of Valvular Interstitial Cells Calcification In Vitro","volume":"5","author":"Lerman","year":"2015","journal-title":"Int. J. Cardiovasc. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/ATVBAHA.119.313067","article-title":"Aortic Valve Stenosis: From Basic Mechanisms to Novel Therapeutic Targets","volume":"40","author":"Goody","year":"2020","journal-title":"ATVB"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4997\/JRCPE.2017.217","article-title":"Aortic Stenosis\u2014Pathogenesis, Prediction of Progression, and Percutaneous Intervention","volume":"47","author":"Natarajan","year":"2017","journal-title":"J. R. Coll. Physicians Edinb."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1053\/j.semtcvs.2021.11.002","article-title":"Commentary: Osteogenic Metaplasia of the Aortic Valve. Do Bacteria, Diabetes, and Dyslipidemia Play a Role?","volume":"34","author":"Dokollari","year":"2022","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/ATVBAHA.123.320271","article-title":"Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis","volume":"44","author":"Schultz","year":"2024","journal-title":"ATVB"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Matilla, L., Mart\u00edn-N\u00fa\u00f1ez, E., Garaikoetxea, M., Navarro, A., Vico, J.A., Arrieta, V., Garc\u00eda-Pe\u00f1a, A., Fern\u00e1ndez-Celis, A., Gainza, A., and \u00c1lvarez, V. (2022). Characterization of the Sex-Specific Pattern of Angiogenesis and Lymphangiogenesis in Aortic Stenosis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.971802"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/atm.2017.11.30","article-title":"Hypertension, Aortic Stenosis, and Aortic Regurgitation","volume":"6","author":"Aronow","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1007\/s11033-014-3434-9","article-title":"Genetic Predisposition to Calcific Aortic Stenosis and Mitral Annular Calcification","volume":"41","author":"Kutikhin","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"ref_58","first-page":"261","article-title":"Arterial Hypertension and Aortic Valve Stenosis: Shedding Light on a Common \"Liaison\"","volume":"58","author":"Liakos","year":"2017","journal-title":"Hell. J. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/eurheartj\/ehae666.3651","article-title":"Rare Genetic Variants in LDLR, APOB, and PCSK9 Are Associated with Aortic Stenosis","volume":"45","author":"Jurgens","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Seo, J.H., Kim, K.H., Chun, K.J., Lee, B.-K., Cho, B.-R., and Ryu, D.R. (2023). Impact of Low-Density Lipoprotein Cholesterol on Progression of Aortic Valve Sclerosis and Stenosis. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1171703"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e21382","DOI":"10.1096\/fj.202002013RR","article-title":"Tumor Necrosis Factor-\u03b1 Promotes and Exacerbates Calcification in Heart Valve Myofibroblast Populations","volume":"35","author":"Schroeder","year":"2021","journal-title":"FASEB J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12265-016-9679-z","article-title":"Calcific Aortic Valve Disease: Part 1\u2014Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks","volume":"9","author":"Pasipoularides","year":"2016","journal-title":"J. Cardiovasc. Trans. Res."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Cavalcante, P.N., Kanhouche, G., Rosa, V.E.E., Campos, C.M., Lopes, M.P., Lopes, M.A.A.A.D.M., Sampaio, R.O., Brito J\u00fanior, F.S.D., Tarasoutchi, F., and Abizaid, A.A.C. (2023). B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Severe Aortic Stenosis: A Comprehensive Literature Review. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1182530"},{"key":"ref_64","first-page":"501","article-title":"Usefulness of Serial B-Type Natriuretic Peptide Assessment in Asymptomatic Aortic Stenosis","volume":"47","author":"Westphalen","year":"2014","journal-title":"J. Emerg. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/heartjnl-2020-316722","article-title":"Lipoprotein-Associated Phospholipase A2 Activity, Genetics and Calcific Aortic Valve Stenosis in Humans","volume":"106","author":"Perrot","year":"2020","journal-title":"Heart"},{"key":"ref_66","first-page":"47","article-title":"Biomarkers Associated with Aortic Stenosis and Structural Bioprosthesis Dysfunction","volume":"38","author":"Oury","year":"2020","journal-title":"Cardiol. Clin."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jacc.2021.04.102","article-title":"Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol","volume":"78","author":"Schwartz","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.7150\/thno.83914","article-title":"PCSK9 Attenuates Efferocytosis in Endothelial Cells and Promotes Vascular Aging","volume":"13","author":"Liu","year":"2023","journal-title":"Theranostics"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","article-title":"Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis","volume":"66","author":"Capoulade","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic Associations with Valvular Calcification and Aortic Stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) Reduction in Persons with Cardiovascular Disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense Oligonucleotides Targeting Apolipoprotein(a) in People with Raised Lipoprotein(a): Two Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Trials","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease","volume":"387","author":"Rosenson","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jacc.2013.05.105","article-title":"Elevated Expression of Lipoprotein-Associated Phospholipase A2 in Calcific Aortic Valve Disease","volume":"63","author":"Mahmut","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41569-018-0123-8","article-title":"Cardiovascular Calcification: Artificial Intelligence and Big Data Accelerate Mechanistic Discovery","volume":"16","author":"Rogers","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.numecd.2021.11.015","article-title":"Synergistic Actions between Angiotensin-Converting Enzyme Inhibitors and Statins in Atherosclerosis","volume":"32","author":"Borghi","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Poznyak, A.V., Bharadwaj, D., Prasad, G., Grechko, A.V., Sazonova, M.A., and Orekhov, A.N. (2021). Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD. IJMS, 22.","DOI":"10.3390\/ijms22136702"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ahj.2011.06.015","article-title":"Measuring and Targeting Aldosterone and Renin in Atherosclerosis\u2014A Review of Clinical Data","volume":"162","author":"Hillaert","year":"2011","journal-title":"Am. Heart J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4","DOI":"10.18087\/cardio.n328","article-title":"The Renin-Angiotensin-Aldosterone System as a Potential Target for Therapy in Patients with Calcific Aortic Stenosis: A Literature Review","volume":"59","author":"Kostyunin","year":"2019","journal-title":"Kardiologiia"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jacc.2011.01.063","article-title":"Impact of Renin-Angiotensin System Blockade Therapy on Outcome in Aortic Stenosis","volume":"58","author":"Nadir","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.2147\/DDDT.S249846","article-title":"DPP-4 Inhibitor Linagliptin Ameliorates Oxidized LDL-Induced THP-1 Macrophage Foam Cell Formation and Inflammation","volume":"14","author":"Wang","year":"2020","journal-title":"DDDT"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00210-022-02279-3","article-title":"Cardiovascular Protection by DPP-4 Inhibitors in Preclinical Studies: An Updated Review of Molecular Mechanisms","volume":"395","author":"Zakaria","year":"2022","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.atherosclerosis.2020.03.029","article-title":"Effects of Dipeptidyl Peptidase 4 Inhibition on Inflammation in Atherosclerosis: A 18F-Fluorodeoxyglucose Study of a Mouse Model of Atherosclerosis and Type 2 Diabetes","volume":"305","author":"Virta","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"106854","DOI":"10.1016\/j.vph.2021.106854","article-title":"Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Apoptosis of Vascular Smooth Muscle Cells and Reduces Atherosclerosis in Diabetic Apolipoprotein E\u2013Deficient Mice","volume":"140","author":"Li","year":"2021","journal-title":"Vasc. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.121.057008","article-title":"Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial","volume":"145","author":"Diederichsen","year":"2022","journal-title":"Circulation"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"117307","DOI":"10.1016\/j.atherosclerosis.2023.117307","article-title":"The Effect of Six-Month Oral Vitamin K Supplementation on Calcification Propensity Time in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial","volume":"394","author":"Meer","year":"2024","journal-title":"Atherosclerosis"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Vlasschaert, C., Goss, C.J., Pilkey, N.G., McKeown, S., and Holden, R.M. (2020). Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials. Nutrients, 12.","DOI":"10.3390\/nu12102909"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e032571","DOI":"10.1161\/JAHA.123.032571","article-title":"Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial","volume":"13","author":"Geers","year":"2024","journal-title":"JAHA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","article-title":"Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial","volume":"143","author":"Pawade","year":"2021","journal-title":"Circulation"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11657-025-01546-z","article-title":"Role of Denosumab in Lipid Metabolism Disorders: Clinical Significance and Potential Mechanisms","volume":"20","author":"Lou","year":"2025","journal-title":"Arch. Osteoporos."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacbts.2019.10.004","article-title":"Celastrol Alleviates Aortic Valve Calcification Via Inhibition of NADPH Oxidase 2 in Valvular Interstitial Cells","volume":"5","author":"Liu","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Shi, J., Cheng, Y., Wang, C., Liu, M., Qu, M., Zhou, S., Chen, L., Li, X., Luo, J., and Luo, Y. (2025). Effects of Celastrol-Enriched Peanuts on Metabolic Health and the Development of Atherosclerosis. Nutrients, 17.","DOI":"10.3390\/nu17091418"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Li, Y., Xue, X., Yu, L., Qian, J., Li, X., Tian, M., Yang, J., Deng, R., Lu, C., and Xiao, C. (2025). Recombinant High-Density Lipoprotein Targeted Delivery of Celastrol to Promote Foam Cells Lipophagy against Early Atherosclerosis. J. Nanobiotechnology, 23.","DOI":"10.1186\/s12951-025-03327-9"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Gu, L., Bai, W., Li, S., Zhang, Y., Han, Y., Gu, Y., Meng, G., Xie, L., Wang, J., and Xiao, Y. (2013). Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065477"},{"key":"ref_96","first-page":"1684","article-title":"Celastrol May Have an Anti-Atherosclerosis Effect in a Rabbit Experimental Carotid Atherosclerosis Model","volume":"7","author":"Zhu","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jacbts.2019.12.010","article-title":"Ancient Remedy for a Modern Disease","volume":"5","author":"Yeang","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"151885","DOI":"10.1016\/j.aanat.2021.151885","article-title":"Emodin Alleviates Aortic Valvular Calcification by Inhibiting the AKT\/FOXO1 Pathway","volume":"240","author":"Luo","year":"2022","journal-title":"Ann. Anat.-Anat. Anz."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s44161-022-00175-w","article-title":"Loss of Soluble Guanylyl Cyclase in Platelets Contributes to Atherosclerotic Plaque Formation and Vascular Inflammation","volume":"1","author":"Mauersberger","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"H756","DOI":"10.1152\/ajpheart.00263.2021","article-title":"Impaired Macrophage Trafficking and Increased Helper T-Cell Recruitment with Loss of Cadherin-11 in Atherosclerotic Immune Response","volume":"321","author":"Johnson","year":"2021","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/ATVBAHA.112.300278","article-title":"Cadherin-11 Regulates Cell\u2013Cell Tension Necessary for Calcific Nodule Formation by Valvular Myofibroblasts","volume":"33","author":"Hutcheson","year":"2013","journal-title":"ATVB"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/ATVBAHA.114.305095","article-title":"Notch1 Mutation Leads to Valvular Calcification Through Enhanced Myofibroblast Mechanotransduction","volume":"35","author":"Chen","year":"2015","journal-title":"ATVB"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s10020-023-00619-4","article-title":"Inhibition of miR-101-3p Prevents Human Aortic Valve Interstitial Cell Calcification through Regulation of CDH11\/SOX9 Expression","volume":"29","author":"Chen","year":"2023","journal-title":"Mol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/ATVBAHA.116.307812","article-title":"Cadherin-11 Overexpression Induces Extracellular Matrix Remodeling and Calcification in Mature Aortic Valves","volume":"36","author":"Sung","year":"2016","journal-title":"ATVB"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/CIRCULATIONAHA.117.027771","article-title":"Targeting Cadherin-11 Prevents Notch1-Mediated Calcific Aortic Valve Disease","volume":"135","author":"Clark","year":"2017","journal-title":"Circulation"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e131545","DOI":"10.1172\/jci.insight.131545","article-title":"Cadherin-11 Blockade Reduces Inflammation-Driven Fibrotic Remodeling and Improves Outcomes after Myocardial Infarction","volume":"4","author":"Schroer","year":"2019","journal-title":"JCI Insight"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCRESAHA.118.313374","article-title":"Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1\u2013Mediated Metabolic and Epigenetic Changes","volume":"124","author":"Miyagawa","year":"2019","journal-title":"Circ. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.omtn.2020.06.024","article-title":"circRNA Hipk3 Induces Cardiac Regeneration after Myocardial Infarction in Mice by Binding to Notch1 and miR-133a","volume":"21","author":"Si","year":"2020","journal-title":"Mol. Ther.-Nucleic Acids"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1172\/JCI42666","article-title":"Integration of a Notch-Dependent Mesenchymal Gene Program and Bmp2-Driven Cell Invasiveness Regulates Murine Cardiac Valve Formation","volume":"120","author":"Prados","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/bdra.20815","article-title":"Notch Signaling in Cardiac Valve Development and Disease","volume":"91","author":"MacGrogan","year":"2011","journal-title":"Birth Defects Res."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Burnstock, G. (2017). Purinergic Signalling: Therapeutic Developments. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00661"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/CIRCRESAHA.107.162271","article-title":"Binding of the P2Y2 Nucleotide Receptor to Filamin A Regulates Migration of Vascular Smooth Muscle Cells","volume":"102","author":"Yu","year":"2008","journal-title":"Circ. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/ATVBAHA.116.308561","article-title":"Endothelial Cell\u2013Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice","volume":"37","author":"Chen","year":"2017","journal-title":"ATVB"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Moschetta, D., Di Maria, E., Valerio, V., Massaiu, I., Bozzi, M., Songia, P., D\u2019alessandra, Y., Myasoedova, V.A., and Poggio, P. (2022). Purinergic Receptor P2Y2 Stimulation Averts Aortic Valve Interstitial Cell Calcification and Myofibroblastic Activation. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020457"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yjmcc.2015.03.002","article-title":"Carbonic Anhydrase XII in Valve Interstitial Cells Promotes the Regression of Calcific Aortic Valve Stenosis","volume":"82","author":"Bouchareb","year":"2015","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8163\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:34:10Z","timestamp":1760034850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":115,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26178163"],"URL":"https:\/\/doi.org\/10.3390\/ijms26178163","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}